Trial Profile
Prospective cohort study identifying the predictors of TNF-α antagonist response to etanercept therapy in rheumatoid arthritis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 10 Feb 2016 New trial record